Raúl Gómez Román

TL;DR: The Coalition for Epidemic Preparedness Innovations has developed and is continuously maintaining an overview of the global landscape of COVID-19 vaccine development activity, which includes vaccine development programmes reported through the WHO's authoritative and continually updated list, along with other projects identified from publicly available and proprietary sources.

TL;DR: In this article, the authors summarized novel and traditional approaches for COVID-19 vaccine development including inactivated, attenuated, nucleic acid, vector and protein based, and showed comparative immunogenicity profiles of various vaccines in clinical phases.

TL;DR: The Coalition for Epidemic Preparedness Innovation (CEPI) is an innovative global partnership between public, private, philanthropic, and civil society organizations that was launched as the result of a consensus that a coordinated, international, and intergovernmental plan was needed to develop and deploy new vaccines to prevent future epidemics.

TL;DR: Key lessons learned from Nipah that could be applied to the understanding of the COVID-19 pandemic and to preparedness against future emerging infectious diseases (EIDs) of pandemic potential are reflected.

TL;DR: This review summarizes the current understanding of NiV pathogenesis and innate and adaptive immune responses induced upon infection and found that the adaptive immune response was stimulated upon NiV infection.